INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹128 Cr | ₹94 Cr | ₹68 Cr | ₹64 Cr | ₹34 Cr |
What is the latest Consolidated Net Profit of INNOVA CAPTAB ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹128 Cr |
| Mar2025 | ₹94 Cr |
| Mar2024 | ₹68 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹34 Cr |
How is Consolidated Net Profit of INNOVA CAPTAB Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹128 Cr | 35.95 | |
| Mar2025 | ₹94 Cr | 38.84 | |
| Mar2024 | ₹68 Cr | 6.54 | |
| Mar2023 | ₹64 Cr | 85.30 | |
| Mar2022 | ₹34 Cr | - | |
Compare Consolidated Net Profit of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹5,897.9 Cr | 6.7% | -17.4% | 30.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 6.7% |
-17.4% |
30.8% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses